Cas:61325-23-3 Methyl 4-(2-aminoanilino)-2,5-dihydrothiophene-3-carboxylate manufacturer & supplier

Chemical Name:Methyl 4-(2-aminoanilino)-2,5-dihydrothiophene-3-carboxylate

CAS.NO:61325-23-3

Synonyms:methyl 3-(2-aminoanilino)-2,5-dihydrothiophene-4-carboxylate;3-(2-aminoanilino)-4-(carbomethoxy)-2,5-dihydrothiophene;HMS554D05

Molecular Formula:C₁₂H₁₄N₂O₂S

Molecular Weight:250.31700

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:89.65000

Exact Mass:250.07800

LogP:2.50880

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like methyl 3-(2-aminoanilino)-2,5-dihydrothiophene-4-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,HMS554D05 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,HMS554D05 Use and application,methyl 3-(2-aminoanilino)-2,5-dihydrothiophene-4-carboxylate technical grade,usp/ep/jp grade.

Related News: One source familiar with the matter told Reuters that the J&J doses are expected to be exported to other countries. The doses are already in vials and ready for use, the other source said. Methyl 4-(2-aminoanilino)-2,5-dihydrothiophene-3-carboxylate manufacturer One source familiar with the matter told Reuters that the J&J doses are expected to be exported to other countries. The doses are already in vials and ready for use, the other source said. Methyl 4-(2-aminoanilino)-2,5-dihydrothiophene-3-carboxylate supplier This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug. Methyl 4-(2-aminoanilino)-2,5-dihydrothiophene-3-carboxylate vendor Hong Kong confirmed its 14th coronavirus case late Saturday. The patient, an 80-year-old man, had traveled for a few hours to mainland China in early January, and later spent several days on a cruise ship in Japan with more than 3,000 passengers and employees. Methyl 4-(2-aminoanilino)-2,5-dihydrothiophene-3-carboxylate factory This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug.